Thoratec Announces FDA Approval To Commence REVIVE-IT Study Utilizing …PR Newswire (press release)… for Circulatory Support at the UM-CVC, to whom the REVIVE-IT IDE was issued, and Robert Kormos , M.D., director of the University of Pittsburgh Medi…
Competition affects who gets a liver transplantFox NewsWhen more than one center has patients on the same donor list, the centers have an incentive to get organs for as many of their own patients as possible, wrote researchers, whose report appeared in…
Competition affects who gets a liver transplant: studyReuters IndiaWhen more than one center has patients on the same donor list, the centers have an incentive to get organs for as many of their own patients as possible, wrote researchers, whose report…
|
PharmaIN receives FDA orphan-drug designation for terlipressin to treat ascites
News-Medical.net People with ascites are also often candidates for liver transplantation. Elijah Bolotin , PhD, President of PharmaIN, said, “Orphan-drug designation by the FDA indicates the importance of this new drug candidate to a desperately ill group of patients … |
 Leadership Newspapers |
AWAK Technologies Enters into an Exclusive Agreement with Baxter …
The Herald | HeraldOnline.com People with ESRD undergo either renal transplantation or dialysis. Since renal transplantation is highly dependent on patient’s health and age, dialysis scores over as the primary treatment. It was estimated as of 2011, there were 2.7 million ESRD … Coping With Challenges OfLeadership Newspapers |
Competition affects who gets a liver transplant: studyYahoo! News (blog)When more than one center has patients on the same donor list, the centers have an incentive to get organs for as many of their own patients as possible, wrote researchers, whose r…
(Reuters) – More competition between medical centers that perform liver transplants may mean sicker patients get lower-quality donor organs, according to a U.S. study. When more than one center has patients on the same donor list, the centers have an i…
Alnylam Provides Key 2013 – 2014 Goals for RNAi Therapeutics PipelineMarketWatch (press release)FAP patients have a life expectancy of five to 15 years from symptom onset, and the only treatment options for early stage disease are liver transplantation…
 Philadelphia Inquirer |
Technology aims to improve lung transplant odds
Philadelphia Inquirer Jay K. Bhama, associate director of lung and heart transplantation at the University of Pittsburgh Medical Center, said such innovations “have a lot of potential in terms of improving the utilization of donor lungs, and helping us assess lungs that may … |
 दैनिक जागरण |
बेंगलूर में किडनी रैकेट का भंडाफोड़, सात गिरफ्तार
दैनिक जागरण Seven arrested in kidney transplantation racket. बेंगलूर में किडनी रैकेट का भंडाफोड़, सात गिरफ्तार. बेंगलूर। कर्नाटक पुलिस ने गैर कानूनी तरीके से किडनी निकालने और उसे बेचने का धंधा करने वाले रैकेट का … |